Literature DB >> 22942552

Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices.

Wael E A Saad, Michael D Darcy.   

Abstract

Variceal bleeding is one of the major complications of portal hypertension. Gastric variceal bleeding is less common than esophageal variceal bleeding; however, it is associated with a high morbidity and mortality rate and its management is largely uncharted due to a relatively less-established literature. In the West (United States and Europe), the primary school of management is to decompress the portal circulation utilizing the transjugular intrahepatic portosystemic shunt (TIPS). In the East (Japan and South Korea), the primary school of management is to address the gastric varices (GVs) specifically by sclerosing them utilizing the balloon-occluded retrograde transvenous obliteration (BRTO) procedure. The concept (1970s), evolution, and development (1980s-1990s) of both procedures run parallel to one another; neither is newer than the other is. The difference is that one was adopted mostly by the East (BRTO), while the other has been adopted mostly by the West (TIPS). TIPS is effective in emergently controlling bleeding for GVs even though the commonly referenced studies about managing GVs with TIPS are studies with TIPS created by bare stents. However, the results have improved with the use of stent grafts for creating TIPS. Nevertheless, TIPS cannot be tolerated by patients with poor hepatic reserve. BRTO is equally effective in controlling bleeding GVs as well as significantly reducing the GV rebleed rate. But the resultant diversion of blood flow into the portal circulation, and in turn the liver, increases the risk of developing esophageal varices and ectopic varices with their potential to bleed. Unlike TIPS, the blood diversion that occurs after BRTO improves, if not preserves, hepatic function for 6-9 months post-BRTO. The authors discuss the detailed results and critique the literature, which has evaluated and remarked on both procedures. Future research prospects and speculation as to the ideal patients for each procedure are discussed.

Entities:  

Keywords:  BRTO; History; TIPS; rebleeding; transvenous obliteration; varices

Year:  2011        PMID: 22942552      PMCID: PMC3312168          DOI: 10.1055/s-0031-1284461

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  93 in total

1.  Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

Authors:  Christophe Bureau; Juan Carlos Garcia-Pagan; Philippe Otal; Gilles Pomier-Layrargues; Valérie Chabbert; Carlos Cortez; Pierre Perreault; Jean Marie Péron; Juan G Abraldes; Louis Bouchard; José Ignacio Bilbao; Jaume Bosch; Hervé Rousseau; Jean Pierre Vinel
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 2.  Transcatheter obliteration of gastric varices. Part 1. Anatomic classification.

Authors:  Hiro Kiyosue; Hiromu Mori; Shunro Matsumoto; Yasunari Yamada; Yuzo Hori; Yuriko Okino
Journal:  Radiographics       Date:  2003 Jul-Aug       Impact factor: 5.333

Review 3.  Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features.

Authors:  Hiro Kiyosue; Hiromu Mori; Shunro Matsumoto; Yasunari Yamada; Yuzo Hori; Yuriko Okino
Journal:  Radiographics       Date:  2003 Jul-Aug       Impact factor: 5.333

4.  A new era for transjugular intrahepatic portosystemic shunts?

Authors:  Richard R Saxon
Journal:  J Vasc Interv Radiol       Date:  2004-03       Impact factor: 3.464

5.  Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.

Authors:  Bernhard Angermayr; Manfred Cejna; Franz Koenig; Franz Karnel; Franz Hackl; Alfred Gangl; Markus Peck-Radosavljevic
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

6.  Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.

Authors:  Young Ho Choi; Chang Jin Yoon; Jae Hyung Park; Jin Wook Chung; Jong Won Kwon; Guk Myung Choi
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

7.  Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.

Authors:  Yasunao Miyamoto; Kazuhiko Oho; Masafumi Kumamoto; Atsushi Toyonaga; Michio Sata
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

8.  Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.

Authors:  Hector Ferral; Pablo Gamboa; Darren W Postoak; Vanessa S Albernaz; Carmen R Young; Kermitt V Speeg; C Alex McMahan
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

9.  Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.

Authors:  Klaus A Hausegger; Franz Karnel; Buriana Georgieva; Josef Tauss; Horst Portugaller; Hannes Deutschmann; Andrea Berghold
Journal:  J Vasc Interv Radiol       Date:  2004-03       Impact factor: 3.464

10.  [The clinical usefulness of balloon occluded retrograde transvenous obliteration in gastric variceal bleeding].

Authors:  Eun Soo Kim; Soo Young Park; Ki Tae Kwon; Dong Seok Lee; Min Jae Park; In Kwon Chung; Jin Hyung Park; Chang Min Cho; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Yong Whan Choi; Chang Kyu Seong
Journal:  Taehan Kan Hakhoe Chi       Date:  2003-12
View more
  29 in total

1.  Balloon Retrograde Transvenous Obliteration for Treatment of Persistent Gastric Variceal Bleed in Patient With Hepatocellular Carcinoma.

Authors:  Jaimy Villavicencio Kim; Ismail Elkhattib; Daniela Guerrero Vinsard
Journal:  Cureus       Date:  2020-06-24

Review 2.  Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Authors:  Paul V Suhocki; Matthew P Lungren; Baljendra Kapoor; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 3.  Evolution of Retrograde Transvenous Obliteration Techniques.

Authors:  Mihir Patel; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

Review 4.  Combining Transjugular Intrahepatic Portosystemic Shunt with Balloon-Occluded Retrograde Transvenous Obliteration or Augmenting TIPS with Variceal Embolization for the Management of Gastric Varices: An Evolving Middle Ground?

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

Review 5.  Endoscopic management of bleeding gastric varices--an updated overview.

Authors:  Dana Crisan; Marcel Tantau; Alina Tantau
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 6.  Nonendoscopic management strategies for acute esophagogastric variceal bleeding.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Gastroenterol Clin North Am       Date:  2014-09-27       Impact factor: 3.806

Review 7.  An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.

Authors:  Seung Kwon Kim; Bryan G Belikoff; Carlos J Guevara; Seong Jin Park
Journal:  Dig Dis Sci       Date:  2017-01-05       Impact factor: 3.199

Review 8.  Update on gastric varices.

Authors:  Maria Triantafyllou; Adrian J Stanley
Journal:  World J Gastrointest Endosc       Date:  2014-05-16

Review 9.  Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches.

Authors:  Andrew J Lipnik; Mithil B Pandhi; Ramzy C Khabbaz; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

10.  Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.